Skip to main content

Vitamin B12 transport defects

Vitamin B12 transport defects



Overview

Vitamin B12 transport defects are rare congenital disorders, such as Transcobalamin II (TC II) deficiency, that prevent cobalamin from reaching tissues, causing severe cellular deficiency despite normal serum B12 levels. These genetic conditions lead to megaloblastic anemia, developmental delay, and neurological issues in infants, often requiring lifelong treatment.

Symptoms

Neurological Symptoms (Severe): Developmental delays, ataxia (difficulty walking), tremor, convulsions, hypotonia (weak muscle tone), and tingling or numbness (paresthesia).

Hematological Issues: Megaloblastic anemia, causing profound fatigue, weakness, dizziness, and pale or yellowish skin.

Gastrointestinal Distress: Persistent vomiting, diarrhea, and failure to gain weight/grow properly in infants.

Mucosal and Skin Issues: Sore mouth or tongue (glossitis), skin hyperpigmentation, and dermatitis.

Psychological Changes: Irritability, confusion, and potential cognitive decline.

Causes

Inherited/Genetic Transport Defects

Transcobalamin II Deficiency: A rare, severe inherited disorder impairing the transport of cobalamin (vitamin B12) from blood into cells.

ABCD4 Deficiency (cblJ-Hcy-MMA): A rare genetic disease affecting lysosomal transport of cobalamin.

MMADHC Mutation (cblD defect): Genetic errors in the C2orf25 gene that affect intracellular metabolism. 

  1. Severe Neurological Impairment 

Subacute Combined Degeneration (SCD): Progressive deterioration of the spinal cord (dorsal and lateral columns) leading to spasticity, ataxia, and severe sensory impairment.

Developmental Delays & Cognitive Decline: Infants often experience intellectual disability, failure to thrive, and severe developmental regressions.

Movement & Behavioral Disorders: Muscle twitches (myoclonus), progressive weakness, paraparesis (leg weakness), irritability, and apathy.

Peripheral Neuropathy: Numbness, tingling (paresthesia), and loss of coordination.

Acquired/Functional Transport Disruptions 

Pernicious Anemia: Autoimmune destruction of parietal cells, reducing intrinsic factor (IF) needed for B12 absorption.

Food-Cobalamin Malabsorption: Failure to release B12 from protein in food, common in elderly due to gastritis.

Surgical Interventions: Gastrectomy or gastric bypass disrupts IF production; ileal resection prevents B12 absorption.

Medications: Long-term use of Proton Pump Inhibitors (PPIs) and metformin can hinder transport and absorption.

Inflammatory Conditions: Crohn's disease, celiac disease, or parasites in the small intestine can impair absorption.

Toxin Exposure: Nitrous oxide inactivates vitamin B12, causing functional deficiency. 

Risk Factors

Inherited Transport Defects (TCII Deficiency)

Consanguinity: Both parents carrying the mutated TCN2 gene.

Genetic Inheritance: Autosomal recessive, meaning both copies of the TCN2 gene must have mutations.

Early Infancy: Symptoms often appear in the first few weeks or months of life (failure to thrive, anemia).

Acquired/Related Risk Factors for Functional Transport/Absorption Defects

While the congenital TCII defect is rare, other conditions that hinder B12 absorption or transport (functional deficiency) are common: 

Older Age (>65–75 years): Often due to atrophic gastritis or achlorhydria (lack of acid to release B12).

Autoimmune Disorders: Pernicious anemia, which produces antibodies against intrinsic factor, and related conditions like Hashimoto’s disease or vitiligo.

Gastrointestinal Surgeries: Gastrectomy (stomach removal), ileal resection (terminal ileum removal), or bariatric surgeries (e.g., Roux-en-Y gastric bypass).

Medications: Long-term use of proton pump inhibitors (PPIs), H2 blockers, and metformin.

Dietary Factors: Long-term strict vegetarian or vegan diets without supplementation.

Renal Disorders: Can lead to impaired cellular absorption of holo-transcobalamin.

Nitrous Oxide Exposure: Inactivates B12 and disrupts methionine synthase.

Complications

1. Severe Neurological Impairment 

Subacute Combined Degeneration (SCD): Progressive deterioration of the spinal cord (dorsal and lateral columns) leading to spasticity, ataxia, and severe sensory impairment.

Developmental Delays & Cognitive Decline: Infants often experience intellectual disability, failure to thrive, and severe developmental regressions.

Movement & Behavioral Disorders: Muscle twitches (myoclonus), progressive weakness, paraparesis (leg weakness), irritability, and apathy.

Peripheral Neuropathy: Numbness, tingling (paresthesia), and loss of coordination.

2. Hematological (Blood) Disorders

Megaloblastic Anemia: A severe form of anemia where blood cells are abnormally large, immature, and incapable of carrying oxygen effectively.

Pancytopenia: A shortage of all blood cell types (red cells, white cells, and platelets), which can lead to severe infections, fatigue, and bleeding problems.

Neutropenia: A specific reduction in white blood cells (neutrophils), severely compromising the immune system. 

3. Metabolic and Developmental Complications

Failure to Thrive: In infants, this manifests as severe feeding difficulties, vomiting, diarrhea, and a failure to gain weight or grow.

Metabolic Crisis: High levels of methylmalonic acid and homocysteine accumulate in the blood and urine, leading to metabolic acidosis.

Mucous Membrane Ulcers: Open sores (ulcers) in the mouth and gastrointestinal tract.

4. Long-term/Irreversible Damage 

Irreversible Neurological Damage: If treatment is delayed, neurological impairments (dementia, severe motor deficits) can become permanent.

Death: If not treated promptly, the condition is fatal, often due to infections from severe immune dysfunction (neutropenia) or severe anemia

Diagnosis

Congenital defects, specifically Transcobalamin (TC) II deficiency, prevent cellular uptake of cobalamin, leading to functional deficiency even if serum levels are normal.

TC Assays: Measuring transcobalamin II levels in cultured skin fibroblasts.

Genetic Testing: Molecular genetic testing for mutations in the TCN2 gene. 

Treatment

Intramuscular Injections: The primary method for inherited transport defects is high-dose intramuscular (IM) injections (e.g., 1 mg). These injections are usually frequent at first (e.g., weekly) and then adjusted to a maintenance schedule based on monitoring of methylmalonic acid (MMA) and homocysteine (Hcy) levels.

High-Dose Oral Therapy: In some cases, very high doses of oral vitamin B12 (e.g., 1 mg daily) may be used, though injections are preferred for immediate and guaranteed absorption, especially in severe cases.

Monitoring and Lifelong Therapy: Because the underlying transport mechanism is permanently defective, treatment typically lasts for the lifetime of the patient. Regular monitoring of MMA and total homocysteine levels is essential to confirm treatment effectiveness.

Early Intervention: Prompt treatment is crucial in infants with inherited transport defects to prevent serious, long-term developmental and neurological damage.

Treatment should be managed by a pediatric metabolic specialist or hematologist, particularly in children.

Type of Doctor Department : Internal Medicine Specialist (Internist) or a General Physician


Comments

Post a Comment

Popular posts from this blog

Charge Syndrome

Overview CHARGE syndrome is a recognizable genetic syndrome with known pattern of features. It is an extremely complex syndrome, involving extensive medical and physical difficulties that differ from child to child. CHARGE syndrome is correlated with genetic mutation to CHD7 and the prevalence of CHARGE syndrome is 1:10,000-1:15,000 live births. Babies with CHARGE syndrome are often born with life-threatening birth defects. They spend many months in the hospital and undergo many surgeries and other treatments. Swallowing and breathing problems make life difficult even when they come home. Most have hearing two little girls sitting on a carpet, one girl has a trach and is biting her finger.loss, vision loss, and balance problems that delay their development and communication. Despite these seemingly insurmountable obstacles, children with CHARGE syndrome often far surpass their medical, physical, educational, and social expectations. One of the hidden features of CHARGE syndrome is the ...
7 comments
Read more

Dehydration Due to Diarrheal Diseases

Overview Dehydration occurs when you use or lose more fluid than you take in, and your body doesn't have enough water and other fluids to carry out its normal functions. If you don't replace lost fluids, you will get dehydrated. Anyone may become dehydrated, but the condition is especially dangerous for young children and older adults. The most common cause of dehydration in young children is severe diarrhea and vomiting. Older adults naturally have a lower volume of water in their bodies, and may have conditions or take medications that increase the risk of dehydration. This means that even minor illnesses, such as infections affecting the lungs or bladder, can result in dehydration in older adults. Dehydration also can occur in any age group if you don't drink enough water during hot weather — especially if you are exercising vigorously. You can usually reverse mild to moderate dehydration by drinking more fluids, but severe dehydration needs immediate medical treatment. ...
Post a Comment
Read more

Vogt-Koyanagi-Harada (VKH) Disease

  Vogt-Koyanagi-Harada (VKH) Disease Disease Overview Vogt-Koyanagi-Harada disease is a rare disorder of unknown origin that affects many body systems, including as the eyes, ears, skin, and the covering of the brain and spinal cord (the meninges). The most noticeable symptom is a rapid loss of vision. There may also be neurological signs such as severe headache, vertigo, nausea, and drowsiness. Loss of hearing, and loss of hair (alopecia) and skin color may occur along, with whitening (loss of pigmentation) of the hair and eyelashes (poliosis). Signs & Symptoms Vogt-Koyanagi-Harada disease is initially characterized by headaches, very deep pain in the eyes, dizziness (vertigo), and nausea. These symptoms are usually followed in a few weeks by eye inflammation (uveitis) and blurring of vision. This may occur in both eyes at the same time or in one eye first and, a few days later, in the other. The retina may detach and hearing loss may become apparent. The chronic stage follows...
Post a Comment
Read more